US equities
|
ANT
$95.08
▲+14.55%
NVDA
$148.16
▼-1.86%
AMD
$480.11
▼-9.44%
MU
$697.96
▼-1.04%
SPCX
$137.42
▼-4.24%
SNDK
$767.87
▼-1.08%
AMZN
$259.02
▼-3.26%
MSFT
$502.58
▼-1.12%
ANT
$95.08
▲+14.55%
NVDA
$148.16
▼-1.86%
AMD
$480.11
▼-9.44%
MU
$697.96
▼-1.04%
SPCX
$137.42
▼-4.24%
SNDK
$767.87
▼-1.08%
AMZN
$259.02
▼-3.26%
MSFT
$502.58
▼-1.12%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about CAR/T
Recent news which mentions CAR/T
Allogene Craters To 52-Week Low On FDA Clinical Hold Of CAR-T Trials, Drags Peers As Well
October 08, 2021
Tickers
ALLO
AUTL
CLLS
MXCT
Tags
Biotech
Phase 1 Trial
Benzinga
From
Benzinga